Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis
Open Access
- 1 January 2009
- journal article
- Published by SAGE Publications in Biomarker Insights
- Vol. 4, BMI.S645-44
Abstract
Arthritis is a chronic disease with a significant impact on the population. It damages the cartilage, synovium, and bone of the joints causing pain, impairment, and disability in patients. Current methods for diagnosis of and monitoring the disease are only able to detect clinical manifestations of arthritis late in the process. However, with the recent onset of successful treatments for rheumatoid arthritis and osteoarthritis, it becomes important to identify prognostic factors that can predict the evolution of arthritis. This is especially critical in the early phases of disease so that these treatments can be started as soon as possible to slow down progression of the disease. A valuable approach to monitor arthritis would be by measuring biological markers of cartilage degradation and repair to reflect variations in joint remodeling. One such potential biological marker of arthritis is cartilage oligomeric matrix protein (COMP). In various studies, COMP has shown promise as a diagnostic and prognostic indicator and as a marker of the disease severity and the effect of treatment. This review highlights the progress in the utilization of COMP as a biomarker of arthritis.Keywords
This publication has 90 references indexed in Scilit:
- Weekly intra-articular injections of bone morphogenetic protein-7 inhibits osteoarthritis progressionArthritis Research & Therapy, 2008
- Interaction of Cartilage Oligomeric Matrix Protein/Thrombospondin 5 with AggrecanJournal of Biological Chemistry, 2007
- Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritisAnnals of the Rheumatic Diseases, 2006
- Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatmentRheumatology International, 2006
- Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2005
- Interactions between the Cartilage Oligomeric Matrix Protein and MatrilinsJournal of Biological Chemistry, 2004
- Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMPRheumatology, 2004
- Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism.Journal of Clinical Investigation, 1995
- Rheumatoid ArthritisNew England Journal of Medicine, 1990
- Radiological Assessment of Osteo-ArthrosisAnnals of the Rheumatic Diseases, 1957